학술논문
Subcutaneous Epcoritamab in Combination with Rituximab plus Lenalidomide (R2) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial
Document Type
ConferencePaper
Author
Source
BLOOD. 140:1471-1473
Subject
Language
English
English
English
ISSN
0006-4971